About
Isomorphic Labs focuses on AI-driven drug discovery, merging DeepMind’s computational approaches with biomedical research to identify and validate promising therapeutics. By modeling molecular interactions and simulating drug candidates in silico, the platform intends to speed up the discovery process, reduce costs, and tackle previously intractable diseases. Its cutting-edge technology aims to reshape pharmaceutical innovation and bring more treatments to market faster.
